2021 speakers

 

 

 
 

 

 

Elsa Abranches, Group Leader, Section Of Stem Cell Biology, NIBSC/MHRA

Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center

Marco Alessandrini, CTO, Antion Biosciences

Aglaia Athanassiadou, Professor Emeritus, University of Patras

Stephen Badylak, Deputy Director, Mcgowan Institute For Regenerative Medicine, University of Pittsburgh

Stefano Baila, Director of Operations, Anemocyte

Stefano Baila | Director of Operations | Anemocyte » speaking at Advanced Therapies

Chip Baird, Chief Financial Officer, bluebird bio

Frank Barry, Scientific Director, Regenerative Medicine Institute

Frank Barry | Scientific Director | Regenerative Medicine Institute » speaking at Advanced Therapies

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Alix Beaupierre, Transplant and Cellular Therapy Nurse Coordinator, Moffitt Cancer Center

Alix Beaupierre | Transplant and Cellular Therapy Nurse Coordinator | Moffitt Cancer Center » speaking at Advanced Therapies

Richard Beckman, Chief Medical Officer, ReNeuron Group Plc

Buzz Bies, Sr. Vice President & Chief Commercial Officer, MVE Biological Solutions

Buzz Bies | Sr. Vice President & Chief Commercial Officer | MVE Biological Solutions » speaking at Advanced Therapies

Axel Boehnke, Director Market Access EU North, PTC Therapeutics

Jaap Boelens, Chief, Stem Cell Transplantation And Cellular Therapies Pediatrics, Memorial Sloan-Kettering Cancer Center

Luc Boileau, Chairman And Chief Executive Officer, INESSS

Luc Boileau | Chairman And Chief Executive Officer | INESSS » speaking at Advanced Therapies

Daria Bou Dargham, Business Development, Genethon

Philip J. Brooks, Program Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health

Heather Callahan, Director of Licensing, University of Colorado

Bradley Campbell, Chief Business Officer, Amicus Therapeutics Inc

Manuel Carrondo, Professor, iBET: Instituto de Biologia Experimental e Tecnológica

Klaus Cichutek, President, Paul Ehrlich Institute

Francesco Cicirello, Site Quality Head, Adaptimmune

Pierre-Albert Colcomb, Genethon

Pierre-Albert Colcomb |  | Genethon » speaking at Advanced Therapies

Angela Columbano, Head Of Business Development And Partnership, Genethon

Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics

Susan Conway, Critical Care Specialist, Children's National Medical Center

Susan Conway | Critical Care Specialist | Children's National Medical Center » speaking at Advanced Therapies

Christina Coughlin, Chief Medical Officer, Rubius Therapeutics

Doug Danison, VP, Access Value and Evidence Strategy, bluebird bio

Derek Dashti, Founder And Chief Executive Officer, D and P Bioinnovations

Derek Dashti | Founder And Chief Executive Officer | D and P Bioinnovations » speaking at Advanced Therapies

Eric Michael David, Chief Executive Officer, BridgeBio-Gene Therapy

Michele de Guise, Scientific Vice-President, INESSS

Michele de Guise | Scientific Vice-President | INESSS » speaking at Advanced Therapies

Joery De Kock, Professor, Vrije Universiteit Brussel

Joery De Kock | Professor | Vrije Universiteit Brussel » speaking at Advanced Therapies

Freddie Dear, Partner, Syncona

Claudia Diamonte, Clinical Trials Nurse, Memorial Sloan-Kettering Cancer Center

Claudia Diamonte | Clinical Trials Nurse | Memorial Sloan-Kettering Cancer Center » speaking at Advanced Therapies

Graciana Diez-Roux, Chief Scientific Officer, Telethon Institute of Genetics and Medicine

Graciana Diez-Roux | Chief Scientific Officer | Telethon Institute of Genetics and Medicine » speaking at Advanced Therapies

Lei Ding, Lead Scientist, in8bio

Lei Ding | Lead Scientist | in8bio » speaking at Advanced Therapies

Kris Elverum, Senior Vice President Of Business Development And Strategy, Rubius Therapeutics

Kris Elverum | Senior Vice President Of Business Development And Strategy | Rubius Therapeutics » speaking at Advanced Therapies

Victoria English, Victoria English, Co-Founder And Editor, MedNous

Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Fabio Fachin, Head Of Cell Therapy Engineering And Automation, Takeda

Fabio Fachin | Head Of Cell Therapy Engineering And Automation | Takeda » speaking at Advanced Therapies

Frank Fan, CSO and Founder, Nanjing Legend Biotech

Suzanne Farid, Professor of Bioprocess Systems Engineering & Co-Director Future Targeted Healthcare Manufacturing Hub, University College London

Marcie Finney, Associate Director, Cleveland Cord Blood Center

Marcie Finney | Associate Director | Cleveland Cord Blood Center » speaking at Advanced Therapies

Miguel Forte, Chief Executive Officer, Bone Therapeutics

Miguel Forte | Chief Executive Officer | Bone Therapeutics » speaking at Advanced Therapies

Kelly Foster, Moffitt Cancer Center

Kelly Foster |  | Moffitt Cancer Center » speaking at Advanced Therapies

Mike Fraser, Head of EMEA Region, Novartis Gene Therapies

Matthew J Frigault, Clinical Director, Cellular Immunotherapy Program, Massachusetts General Hospital

Matthew J Frigault | Clinical Director, Cellular Immunotherapy Program | Massachusetts General Hospital » speaking at Advanced Therapies

Michela Gabaldo, Head Of Alliance Management, Fondazione Telethon

Joseph Garrity, Head of Autologous Cell Therapy Associate Director, Commercial Development, Lonza

Joseph Garrity | Head of Autologous Cell Therapy Associate Director, Commercial Development | Lonza » speaking at Advanced Therapies

Sara Geary Alexander, Clinical Nurse Specialist, Massachusetts General Hospital

Sara Geary Alexander | Clinical Nurse Specialist | Massachusetts General Hospital » speaking at Advanced Therapies

Daniel Getts, Co-founder & CEO

Dr David Gilham, Vice President Of Research And Development, Celyad

Janet Glassford, Senior Quality Assessor, Medicines & Healthcare Products Regulatory Agency

Janet Glassford | Senior Quality Assessor | Medicines & Healthcare Products Regulatory Agency » speaking at Advanced Therapies

Simon Goldman, Investment Director, Albion Capital

Ian Goodwin, Associate Director, Global Program Design, Fujifilm Diosynth Biotechnologies

Cecilia Gotherstrom, Research Leader And Associate Professor, Karolinska Institutet

Miriam Haak, Business Development Manager, Miltenyi Biotec GmbH

Patrick J Hanley, Director, Cellular Therapy Laboratory, Children's National Medical Center

Patrick J Hanley | Director, Cellular Therapy Laboratory | Children's National Medical Center » speaking at Advanced Therapies

Hansjorg Hauser, Head Of Department Of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Christopher R Heery, Chief Medical Officer, Precision BioSciences

Christopher R Heery | Chief Medical Officer | Precision BioSciences » speaking at Advanced Therapies

Amir Hefni, VP, Global Commercial Head, Cell & Gene, Novartis

Luke Henry, VP Operations & Corporate Development, Quell Therapeutics

Christoph Herwig, Professor Of Biochemical Engineering, Vienna University of Technology

Farid Ighemat, Senior Director Cell and Gene Therapy, GlaxoSmithKline

Farid Ighemat | Senior Director Cell and Gene Therapy | GlaxoSmithKline » speaking at Advanced Therapies

Dr Moshe Israeli, Medical Director, Rabin Medical Center

Troels Jordansen, Chief Executive Officer, Glycostem Therapeutics

Margareth Jorvid, Head of Regulatory Affairs and QA, Immunicum

Margareth Jorvid | Head of Regulatory Affairs and QA | Immunicum » speaking at Advanced Therapies

Steve Kanner, Chief Scientific Officer, Caribou Biosciences

Cornelia Kasper, Professor, Biopharmaceutical Production And Technology, boku

Aisha Khan, Executive Director Of Lab Operations At The Interdisciplinary Stem Cell Institute, Miller School of Medicine University of Miami

Sven Kili, CEO, Antion Biosciences, Principal, Sven Kili Consulting

Sven Kili | CEO, Antion Biosciences, Principal | Sven Kili Consulting » speaking at Advanced Therapies

Michael Klichinsky, Co-Founder, Vice President Of Discovery And Research, Carisma Therapeutics

Michael Klichinsky | Co-Founder, Vice President Of Discovery And Research | Carisma Therapeutics » speaking at Advanced Therapies

Jim Kovach, Director, Innovation

Jim Kovach | Director | Innovation » speaking at Advanced Therapies

Sebastian Kress, Postdoctoral Scientist, Institute of Cell and Tissue Culture Technologies, boku

Joanne Kurtzberg, Professor Of Pediatrics And Pathology; Director, Marcus Center For Cellular Cures,, Duke University Medical Center

Joanne Kurtzberg | Professor Of Pediatrics And Pathology; Director, Marcus Center For Cellular Cures, | Duke University Medical Center » speaking at Advanced Therapies

Lawrence Lamb, Executive Vice President And Chief Scientific Officer, in8bio

Nanxin (Nick) Li, Senior Director and Head, Health Economics and Outcomes Research (HEOR), uniQure

John Maher, CSO, Leucid Bio

Rey Mali, VP of Sales and Marketing, Accellix

Christopher Mann, Scientific And Regulatory Affairs Director, Asphalion, S.L.

Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration

Yoshiaki Maruyama, Review Director, Pmda

Allison Matthews, Service Designer, Mayo Clinic Center for Innovation

David Mazzo, Chief Executive Officer, Caladrius Biosciences

Chris McClain, Senior Vice President, Sales and Business Development, Be The Match BioTherapies

Chris McClain | Senior Vice President, Sales and Business Development | Be The Match BioTherapies » speaking at Advanced Therapies

Sarah Meeks, Vice President Of Business Development, Maxcyte

Leslie Meltzer, Vice President And Head Of Global Medical Affairs, Orchard Therapeutics

Debra Miller, CEO & Founder, CureDuchenne

Debra Miller | CEO & Founder | CureDuchenne » speaking at Advanced Therapies

Federico Mingozzi, Chief Scientific Officer, Spark Therapeutics

Felix Montero Julian, Scientific Director, BioMerieux Inc

Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine

David Morrow, Scientific Program Manager, EATRIS

Snehal Naik, Regulatory Strategy and Policy leader, Spark Therapeutics

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Robin Ng, Strategy Lead, Cellular Biomedicine Group

Robin Ng | Strategy Lead | Cellular Biomedicine Group » speaking at Advanced Therapies

Steve Oh, Stem Cell Bioprocessing Director And Institute Professor, A-star

Daniel O'Mahony, Partner, Seroba Life Sciences

Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmaceutical Economics Consultants of America (PECA) LLC

Detlev Parow, Head Pharmaceutical Department, DAK-Gesundheit

Vivienne Parry, Head Of Engagement, Genomics England

Vivienne Parry | Head Of Engagement | Genomics England » speaking at Advanced Therapies

David Pauza, Chief Science Officer, American Gene Technologies International Inc.

Dr Qasim Rafiq, Associate Professor, Bioprocessing Of Cell And Gene Therapies, University College London

Vasu Rangadass, President CEO, L7 Informatics

Vasu Rangadass | President  CEO | L7 Informatics » speaking at Advanced Therapies

Vasu Rangadass, President CEO, L7 Informatics

Vasu Rangadass | President  CEO | L7 Informatics » speaking at Advanced Therapies

Vardit Ravistsky, Professor, Bioethics Program, Department of Social and Preventive Medicine, School of Public Health, University of Montreal

Lior Raviv, Vice President ,Development & Operations, Pluristem Therapeutics

Albert Ribickas, BMT Laboratory Manager, Moffitt Cancer Center

Jessica Robinson, Project director, Terrapinn Ltd

Jessica Robinson | Project director | Terrapinn Ltd » speaking at Advanced Therapies

Vince Rotello, Charles A. Goessmann Professor of Chemistry and a University Distinguished Professor, University of Massachusetts Amherst

Holger A Russ, Assistant Professor of Pediatrics, University of Colorado

Mark Sawicki, Chief Executive Officer, Cryoport Inc

David Schaffer, Professor, Chemical And Biomolecular Engineering, University Of California, Berkeley And Co-Founder, 4D molecular therapeutics

Dominic Schmidt, Partner, Syncona Investment Management Ltd

Jan Schrooten, CEO & Co-Founder, Antleron

Jan Schrooten | CEO & Co-Founder | Antleron » speaking at Advanced Therapies

Matthew Seefeldt, Executive Director, The Charles Gates Biomanufacturing Facility

Matthew Seefeldt | Executive Director | The Charles Gates Biomanufacturing Facility » speaking at Advanced Therapies

Tamir Singer, Head of Commercial Development, NHS England

Tamir Singer, Head of Commercial Development, NHS England

Tamir Singer | Head of Commercial Development | NHS England » speaking at Advanced Therapies

Devyn Smith, CEO, Arbor Biotechnologies

Owen Smith, Investment Director, 4BIO Capital

Owen Smith | Investment Director | 4BIO Capital » speaking at Advanced Therapies

Mangala Srinivas, CSO, Cenya Imaging; Chair Group Leader,, Wageningen University and Research Centre

Mangala Srinivas | CSO, Cenya Imaging; Chair Group Leader, | Wageningen University and Research Centre » speaking at Advanced Therapies

Dr Glyn Stacey, Executive Director, International Stem Cell Banking Initiative

Dr Glyn Stacey | Executive Director | International Stem Cell Banking Initiative » speaking at Advanced Therapies

Joseph Stavas, Senior Vice President of Clinical Development, ProKidney

Dick Sundh, Vice President, Marketing & Head of Australia, Canada and Europe (ACE),, Kite Pharma, a Gilead Company

Mark D Swartz, best-selling Canadian author and columnist

Hardy Tadahisa S Kagimoto, President And Chief Executive Officer, Healios K. K.

Hardy Tadahisa S Kagimoto | President And Chief Executive Officer | Healios K. K. » speaking at Advanced Therapies

Aristides D Tagalakis, Senior Lecturer, Edge Hill University

Magali Taiel, Chief Medical Officer, GenSight Biologics

Marina Tarunina, Research Director, Plasticell

Stefanos Theoharis, Chief Business Officer, Bone Therapeutics

Stefanos Theoharis | Chief Business Officer | Bone Therapeutics » speaking at Advanced Therapies

Pascal Touchon, President, Chief Executive Officer And Board Member, Atara Biotherapeutics

Pascal Touchon | President, Chief Executive Officer And Board Member | Atara Biotherapeutics » speaking at Advanced Therapies

Sheela Upadhyaya, Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist, National Institute for Health and Care Excellence

Sheela Upadhyaya | Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist | National Institute for Health and Care Excellence » speaking at Advanced Therapies

Anna Veiga, Director, Stem Cell Bank - Center Of Regenerative Medicine In Barcelona

David Venables, President, AskBio Europe, Askbio

Birgitte Volck, Non Executive Director, Soleno Therapeutics

Birgitte Volck | Non Executive Director | Soleno Therapeutics » speaking at Advanced Therapies

John Wagner, Executive Medical Director Of B.M.T. Program, University of Minnesota

John Wagner | Executive Medical Director Of B.M.T. Program | University of Minnesota » speaking at Advanced Therapies

Phil Wilson, Chief Operating Officer, Cryoport

Tom Wilton, Chief Business Officer, Carisma Therapeutics

Masahide Yano, Director/Principal Investigator, Hsiri Therapeutics

Masahide Yano | Director/Principal Investigator | Hsiri Therapeutics » speaking at Advanced Therapies